Rigel Pharmaceuticals
RIGL
#7375
Rank
C$0.46 B
Marketcap
$25.95
Share price
-4.29%
Change (1 day)
79.36%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): C$36.94 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are C$0.17 Billion. , an increase over its 2023 earnings that were of -C$25.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 C$36.42 M-244.27%
2023 -C$25.26 Million-66.79%
2022 -C$76.05 Million340.73%
2021 -C$17.26 Million-56.15%
2020 -C$39.35 Million-57.34%
2019 -C$92.25 Million-7.66%
2018 -C$99.91 Million-9.47%
2017 -C$0.12 Billion24.46%
2016 -C$88.67 Million23.63%
2015 -C$71.72 Million-43.29%
2014 -C$0.13 Billion2.5%
2013 -C$0.13 Billion
2010 C$52.47 M-133.97%
2009 -C$0.16 Billion-18.49%
2008 -C$0.19 Billion71.91%
2007 -C$0.12 Billion84.74%
2006 -C$59.67 Million-10.17%
2005 -C$66.42 Million-15.73%
2004 -C$78.82 Million39.29%
2003 -C$56.59 Million10.3%
2002 -C$51.31 Million48.3%
2001 -C$34.6 Million-2.13%
2000 -C$35.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.19 Billion-596.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.14 Billion-474.55%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.45 B 39,593.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$6.38 B 17,435.38%๐Ÿ‡บ๐Ÿ‡ธ USA